Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government how many COVID-19 vaccination doses they have ordered in total; whether they intend to order more doses than the number required to vaccinate the population of the UK; and if so, what plans they have to ensure that any surplus doses are used effectively.

The UK Government has secured early access to 457 million vaccines doses through agreements with eight separate vaccine developers. This includes agreements with BioNTech/Pfizer, Oxford/AstraZeneca, GlaxoSmithKline and Sanofi Pasteur, Novavax, Janssen, Valneva and Moderna.

The Government continues to monitor the landscape of COVID-19 vaccine development, both here in the UK and internationally, and will keep the situation under review.

My Rt. Hon. Friend the Prime Minister has made clear that equitable access is an integral part of the UK’s approach to vaccine development and distribution. The UK is working with international partners to support vaccine development, manufacturing scale-up and future distribution to meet both domestic and international needs.